Inozyme Pharma (INZY)
(Delayed Data from NSDQ)
$5.13 USD
+0.15 (3.01%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $5.12 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.44 | -0.76% |
Earnings Summary
For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.44 per share, missing the Zacks Consensus Estimate of -$0.37 per share. This reflects a negative earnings surprise of 18.92%. Look out for INZY's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year decrease of 51.72%.
Earnings History
Price & Consensus
Zacks News for INZY
Why Earnings Season Could Be Great for Inozyme (INZY)
INZY: What are Zacks experts saying now?
Zacks Private Portfolio Services